LCLorraine E. Chalifour

Lorraine E. Chalifour

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lorraine E. Chalifour has a total of 71 co-authors. Here are the top co-authors by number of shared publications:

  • Amanda Kasneci

    Lady Davis Institute for Medical Research, Montréal, Québec H3T 1E2, Canada

    3 shared publications
  • Bhavini B. Patel

    Lady Davis Institute for Medical Research, Montréal, Québec H3T 1E2, Canada, Department of Oncology, Jewish General Hospital, 3755 Chemin Cote Ste Catherine, Montréal, Québec H3T 1E2, Canada, Division of Experimental Medicine, Department of Medicine, McGill University, 850 Sherbrooke Street, Montréal, Québec H3A 1A2, Canada, Division of Cardiology and Division of Endocrinology, Jewish General Hospital, 3755 Chemin Cote Ste Catherine, Montréal, Québec H3T 1E2, Canada

    3 shared publications
  • Jijun Shang

    Lady Davis Institute for Medical Research, Jewish General HospitalMontreal, QC, Canada

    3 shared publications
  • Chulmin Cho

    Department of Psychological and Brain Sciences, University of Toronto Mississauga; Mississauga, Ontario, L5L 1C6, Canada

    2 shared publications
  • Eszter Pal

    Lady Davis Institute for Medical Research

    2 shared publications
  • Hemant K. Paudel

    Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec H4H 1R3, Canada; Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec H4H 1R3, Canada

    2 shared publications

Latest Publications

  • Open Access

    Acute myocardial infarction induces sex-specific, time-dependent remodeling of the gut microbiome and intestinal immune compartment in retired breeder C57BL/6N mice

    by Eszter Pal, Neda Omidi Arjenaki, Yao Lu, Jianguo Xia, Lorraine Chalifour

    Introduction: The gut microbiome influences cardiovascular health through metabolite production and immune modulation. Gut microbial dynamics and cardiovascular outcomes are also shaped by biological sex. However, sex-specific responses to myocardial infarction (MI) that involve the gut microbiome and intestinal milieu remain poorly defined, particularly in older hosts. Here, we characterize gut microbiome structure and function alongside physiological and immune responses to MI across multiple tissues in aging male and female mice. Methods: MI was induced by permanent LAD ligation and confirmed by echocardiography in C57BL/6N retired breeder mice. Sham surgery (SH) and no surgery (NoSx) groups served as controls. Gut microbiota and the cecal metabolome were characterized using 16S rRNA sequencing and untargeted UPLC-MS, respectively. Immune cells in the small intestine, heart, bone marrow, and spleen were quantified by flow cytometry, and small intestinal morphology was assessed on H&E-stained sections. Results: Sex-specific differences were evident at baseline. Following MI, pronounced time- and sex-specific differences in gut microbial and immune cell populations were observed, peaking on day 3 (D3) and absent in SH and NoSx controls. Early increases in Bacteroidaceae , Tannerellaceae , and Marinifilaceae were present in both sexes, with sex-specific enrichment of Bacteroidaceae in males and Akkermansiaceae in females. Metabolomic analyses identified increased secondary bile acid derivatives, including cholylvaline in males and 12-oxo-lithocholic acid in females. Integration of microbiota–metabolome data revealed MI-responsive and homeostatic taxa with opposing metabolite signatures, while functional analyses indicated enrichment of propanoate and amino acid metabolism pathways. These changes were temporally aligned with acute MI-induced expansion of intestinal MHCII + CD11c + dendritic cells and TCRαβ + CD4 + , TCRαβ + CD8αβ + , and CD25 + FoxP3 + regulatory T cells on D3 in both sexes. Males alone exhibited marked increases in intestinal TCRγδ + T cells, while females showed increased accumulation of innate immune cells. Discussion: Convergence of peak physiological, immunological, and microbial responses on day 3 after MI reveals coordinated responses across the gut-heart axis that are fundamentally influenced by sex. Our findings highlight the need for personalized, sex-specific perioperative strategies and identify the gut microbiome as a potential therapeutic target to improve outcomes after MI.


  • Open Access

    Identification of a Novel apoB Variant in a Family Exhibiting Hypocholesterolemia: Mechanistic Insights

    by Rachid Essalmani, Alexandra Evagelidis, Michael Chong, Guillaume Pare, Evgeniy V. Petrochenko, Mart Reimund, Alan T Remaley, Lorraine Chalifour, Morris Schweitzer, Nabil G. Seidah

    Familial hypobetalipoproteinemia (FHBL) is a rare autosomal codominant disorder. FHBL is often caused by a defect in apoB production that is required for lipoprotein formation. Here we identified three family members that exhibited very low circulating cholesterol levels. Analyses of their plasma lipid profiles revealed that the affected individuals have low levels of cholesterol and LDL-cholesterol (LDLc) lipoproteins, with no difference in lipoprotein particle size. Sequencing of the APOB gene revealed a single heterozygote deletion of an adenosine in exon 3 at the nucleotide position 1268 in all affected members. This deletion introduces a reading frame shift at glutamine 380 resulting in a stop codon at position 397. This C-terminally truncated apoB, called apoB9, is a variant spanning ~9% of the full-length protein. Upon expression of apoB9 in human hepatocyte IHH cells, the protein was detected intracellularly but it did not exit the endoplasmic reticulum and hence was not secreted into the media. Molecular modeling revealed that apoB9 lacks the βA- and βB-sheets that are required for lipid particle formation, which can explain the absence of apoB9 secretion and the low levels of plasma apoB in the affected family members, likely modifying their risk of developing CVD.

  • Open Access

    A surgical recovery matrix to evaluate post-surgical recovery in mice using sham and myocardial infarction models of cardiac surgery as prototypes

    by Eszter Pal, Brandon Shokoples, Saumya Naik, Kyle Hogue, Lorraine E. Chalifour

    Examinations of biomarkers are useful in measuring overall health. Endpoints are critical to assess the threshold where the scientific aim of the study does not prevail over the wellbeing of experimental laboratory animal. However, parameters able to assess health and recovery after an acute post-surgical intervention are needed. To fill this gap, we combined a suite of qualitative and quantitative measurements and created a surgical recovery matrix (SRM) able to monitor and score rodent health and wellbeing after surgery. We established baseline values in healthy male and female retired breeder C57BL/6N mice as a control, no surgery (NoSx) cohort. To test if SRM scoring was useful in the immediate surgical period, we monitored changes in 18 parameters after sham (SH) and myocardial infarction (MI)-inducing surgeries over 3 days of recovery. The surgical manipulations and cardiac damage involved in MI-inducing surgery render its categorization as a major surgery. In contrast, SH surgery represents a minor surgery such that the surgical manipulations are identical to that of the MI surgery but without any manipulation/damage to the heart. Six hours after surgery, males and females showed deficits in nestlet integration, eye grooming, a hunched posture and rough coat appearance whereas greater body weight losses and impaired wound healing were recorded later in the observation period. Sex-specific differences were observed such that males showed a propensity to reduced mobility and lower surface body temperature whereas females had a reduced Body Condition Score. These parameters discriminated the very low scores detected in controls from the intermediate scores after SH surgery and the highest scores in mice severely debilitated by MI surgery. Further, we identified sex-specific and time-dependent changes such that the highest scores were detected in male mice after an MI versus SH surgery. We conclude that a combination of quantitative and qualitative parameters successfully evaluated mouse recovery and health after minor and major surgery.


  • Open Access

    Exposure to the non-phthalate plasticizer di-heptyl succinate is less disruptive to C57bl/6N mouse recovery from a myocardial infarction than DEHP, TOTM or related di-octyl succinate

    by Adam Schwendt, Joey-Bahige Chammas, Milan Maric, Jim A. Nicell, Richard Leask, Lorraine E. Chalifour

    Phthalate plasticizers are incorporated into plastics to make them soft and malleable, but are known to leach out of the final product into their surroundings with potential detrimental effects to human and ecological health. The replacement of widely-used phthalate plasticizers, such as di-ethylhexyl phthalate (DEHP), that are of known toxicity, by the commercially-available alternative Tris(2-ethylhexyl) tri-mellitate (TOTM) is increasing. Additionally, several newly designed “green” plasticizers, including di-heptyl succinate (DHPS) and di-octyl succinate (DOS) have been identified as potential replacements. However, the impact of plasticizer exposure from medical devices on patient recovery is unknown and, moreover, the safety of TOTM, DHPS, and DOS is not well established in the context of patient recovery. To study the direct effect of clinically based chemical exposures, we exposed C57bl/6 N male and female mice to DEHP, TOTM, DOS, and DHPS during recovery from cardiac surgery and assessed survival, cardiac structure and function, immune cell infiltration into the cardiac wound and activation of the NLRP3 inflammasome. Male, but not female, mice treated in vivo with DEHP and TOTM had greater cardiac dilation, reduced cardiac function, increased infiltration of neutrophils, monocytes, and macrophages and increased expression of inflammasome receptors and effectors, thereby suggesting impaired recovery in exposed mice. In contrast, no impact was detected in female mice and male mice exposed to DOS and DHPS. To examine the direct effects in cells involved in wound healing, we treated human THP-1 macrophages with the plasticizers in vitro and found DEHP induced greater NLRP3 expression and activation. These results suggest that replacing current plasticizers with non-phthalate-based plasticizers may improve patient recovery, especially in the male population. In our assessment, DHPS is a promising possibility for a non-toxic biocompatible plasticizer.


  • Open Access

    TrpNet: Understanding Tryptophan Metabolism across Gut Microbiome

    by Yao Lu, Jasmine Chong, Shiqian Shen, Joey-Bahige Chammas, Lorraine Chalifour, Jianguo Xia

    Crosstalk between the gut microbiome and the host plays an important role in animal development and health. Small compounds are key mediators in this host–gut microbiome dialogue. For instance, tryptophan metabolites, generated by biotransformation of tryptophan through complex host–microbiome co-metabolism can trigger immune, metabolic, and neuronal effects at local and distant sites. However, the origin of tryptophan metabolites and the underlying tryptophan metabolic pathway(s) are not well characterized in the current literature. A large number of the microbial contributors of tryptophan metabolism remain unknown, and there is a growing interest in predicting tryptophan metabolites for a given microbiome. Here, we introduce TrpNet, a comprehensive database and analytics platform dedicated to tryptophan metabolism within the context of host (human and mouse) and gut microbiome interactions. TrpNet contains data on tryptophan metabolism involving 130 reactions, 108 metabolites and 91 enzymes across 1246 human gut bacterial species and 88 mouse gut bacterial species. Users can browse, search, and highlight the tryptophan metabolic pathway, as well as predict tryptophan metabolites on the basis of a given taxonomy profile using a Bayesian logistic regression model. We validated our approach using two gut microbiome metabolomics studies and demonstrated that TrpNet was able to better predict alterations in in indole derivatives compared to other established methods.


  • Open Access

    A Novel Egr-1-Agrin Pathway and Potential Implications for Regulation of Synaptic Physiology and Homeostasis at the Neuromuscular Junction

    by Ryen MacDonald, Sebastien Barbat-Artigas, Chulmin Cho, Huashan Peng, Jijun Shang, Ayman Moustaine, Salvatore Carbonetto, Richard Robitaille, Lorraine E. Chalifour, Hemant Paudel

    Synaptic transmission requires intricate coordination of the components involved in processing of incoming signals, formation and stabilization of synaptic machinery, neurotransmission, and in all related signaling pathways. Changes to any of these components cause synaptic imbalance and disruption of neuronal circuitry. Extensive studies at the neuromuscular junction (NMJ) have greatly aided in the current understanding of synapses and served to elucidate the underlying physiology as well as associated adaptive and homeostatic processes. The heparansulfate proteoglycan agrin is a vital component of the NMJ, mediating synaptic formation and maintenance in both brain and muscle, but very little is known about direct control of its expression. Here, we investigated the relationship between agrin and transcription factor early growth response-1 (Egr-1), as Egr-1 regulates the expression of many genes involved in synaptic homeostasis and plasticity. Using chromatin immunoprecipitation, cell culture with cell lines derived from brain and muscle, and animal models, we show that Egr-1 binds to the AGRN gene locus and suppresses its expression. When compared with wild type (WT), mice deficient in Egr-1 (Egr-1-/-) display a marked increase in AGRN mRNA and agrin full-length and cleavage fragment protein levels, including the 22 kDa, C-terminal fragment in brain and muscle tissue homogenate. Because agrin is a crucial component of the NMJ, we explored possible physiological implications of the Egr-1-agrin relationship. In the diaphragm, Egr-1-/- mice display increased NMJ motor endplate density, individual area, and area of innervation. In addition to increased density, soleus NMJs also display an increase in fragmented and faint endplates in Egr-1-/- versus WT mice. Moreover, the soleus NMJ electrophysiology of Egr-1-/- mice revealed increased quantal content and motor testing showed decreased movement and limb muscle strength compared with WT. This study provides evidence for the potential involvement of a novel Egr-1-agrin pathway in synaptic homeostatic and compensatory mechanisms at the NMJ. Synaptic homeostasis is greatly affected by the process of aging. These and other data suggest that changes in Egr-1 expression may directly or indirectly promote age-related pathologies.


  • From the Cover: Lifelong Exposure of C57bl/6n Male Mice to Bisphenol A or Bisphenol S Reduces Recovery From a Myocardial Infarction

    by Amanda Kasneci, Jun Seong Lee, Tae Jin Yun, Jijun Shang, Shaun Lampen, Tamar Gomolin, Cheolho C. Cheong, Lorraine E. Chalifour

    Bisphenol A (BPA) leaches from plastics to contaminate foodstuffs. Analogs, such as bisphenol S (BPS), are now used increasingly in manufacturing. Greater BPA exposure has been correlated with exacerbation of cardiovascular disease, including myocardial infarction (MI). To test the hypothesis that bisphenol exposure impairs cardiac healing, we exposed C57bl/6n mice to water containing 25ng/ml BPA or BPS from conception and surgically induced an MI in adult male progeny. Increased early death and cardiac dilation, and reduced cardiac function were found post-MI in BPA- and BPS-exposed mice. Flow cytometry revealed increased monocyte and macrophage infiltration that correlated with increased chemokine C-C motif ligand-2 expression in the infarct. In vitro BPA and BPS addition increased matrix metalloproteinase-9 (MMP) protein and secreted activity in RAW264.7 macrophage cells suggesting that invivo increases in MMP2 and MMP9 in exposed infarcts were myeloid-derived. Bone marrow-derived monocytes isolated from exposed mice had greater expression of pro-inflammatory polarization markers when chemokine stimulated indicating an enhanced susceptibility to develop a pro-inflammatory monocyte population. Chronic BPA exposure of estrogen receptor beta (ERβ) deficient mice did not worsen early death, cardiac structure/function, or expression of myeloid markers after an MI. In contrast, BPS exposure of ERβ-deficient mice resulted in greater death and expression of myeloid markers. We conclude that lifelong exposure to BPA or BPS augmented the monocyte/macrophage inflammatory response and adverse remodeling from an MI thereby reducing the ability to survive and successfully recover, and that the adverse effect of BPA, but not BPS, is downstream of ERβ signaling.


  • Early growth response‐1‐mediated down‐regulation of drebrin correlates with loss of dendritic spines

    by Chulmin Cho, Ryen MacDonald, Jijun Shang, Moon Jeong Cho, Lorraine E. Chalifour, Hemant K. Paudel

    Post‐synaptic dendritic spines are structurally composed of actin cytoskeleton, which undergoes dynamic morphological changes to accommodate incoming synaptic activity. Drebrin is an actin‐binding protein highly expressed in dendritic spines that serves an important role in regulating spine morphology. Functionally, loss of drebrin directly correlates with deficits in learning and memory, as is the case observed in Alzheimer's disease. Despite these findings, the regulatory factor responsible for drebrin loss remains unclear. Here, we show that early growth response‐1 (Egr‐1), an inducible zinc finger transcription factor, down‐regulates drebrin expression. Chromatin immunoprecipitation analyses identified Egr‐1 binding sites upstream of the drebrin start site in neuronal cells. Over‐expression of Egr‐1 in vitro in primary hippocampal neurons or in vivo in homogenates prepared from the hippocampi of an inducible mouse model of Egr‐1 show reduced drebrin mRNA and protein levels. Conversely, increased drebrin was detected in hippocampal samples isolated from Egr‐1‐deficient brain. These data demonstrate that Egr‐1 interacts with the drebrin promoter and negatively regulates drebrin expression. Furthermore, immunocytochemical and Golgi staining analyses revealed reduced drebrin protein and dendritic spine density as well as reduced expression of synaptic markers in in vitro hippocampal neurons over‐expressing Egr‐1 and in vivo inducible mouse model of Egr‐1. In contrast, increased drebrin expression correlated with increased dendritic spine density was detected in samples from Egr‐1‐deficient mice. These data provide evidence that Egr‐1 is a novel regulator of drebrin expression, which is linked to changes in dendritic spine density. image